Drugs

targeting G-Protein Coupled Receptor G-Protein Coupled Receptors (GPCRs) are a large family of cell surface receptors that are involved in many important bodily functions and pathways. Drugs that target GPCRs are used to treat a variety of illnesses, such as heart disease, depression, obesity, and cancer. GPCR drugs are designed to bind to the receptor and activate or inhibit its activity, leading to therapeutic effects. GPCRs are also being studied as potential therapeutic targets for a range of other disorders, including diabetes and inflammation. GPCR-targeted drugs are an increasingly important part of modern medicine, with the potential to improve the quality of life for countless patients around the world.

← Journal of Drug Resistant Pathogen Research

Related Articles

6 article(s) found

Current Status of Nonsteroidal Anti-Inflammatory Drugs in Colorectal Cancer Prevention

Full-text HTML Download PDF Download XML

Why New Drugs, Treatments, and Medical Devices Still Needs to be Tested Clinically Before Making it Available in the Market?

Full-text HTML Download PDF Download XML

Successful Cascade of Care and Cure HCV in 5382 Drugs Users: How Increase HCV Treatment by Outreach Care, Since Screening to Treatment

Full-text HTML Download PDF Download XML

Assessment of Self Medication Practice and Drugs Storage Among South Sudanese Community in Addis Ababa, Ethiopia

Full-text HTML Download PDF Download XML

Spirometric profile of people living with HIV on antiretroviral drugs in Abidjan

Full-text HTML Download PDF Download XML

Measuring Quality Change in the Market for Anti-Ulcer Drugs

Full-text HTML Download PDF Download XML